What Glenmark Pharmaceuticals’ Ryaltris commercialization shift means for allergy drug competition
Glenmark Pharmaceuticals is taking direct control of Ryaltris in the U.S. Read what this shift means for allergy drug strategy and specialty growth.
Pharma & Biotech